查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403425

到 2030 年皮下給藥市場預測：按產品類型、適應症、配銷通路和地區分類的全球分析

Subcutaneous Drug Delivery Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Indication, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球皮下給藥市場規模為 309 億美元，預計在預測期內將以 11.3% 的複合年成長率成長，到 2030 年達到 654 億美元。

醫療設備用於對患者給藥皮下或皮下給藥。這種藥物傳遞方法優於其他方法，因為它可以將藥物持續不斷地釋放到循環中，從而產生更少的副作用和更穩定的治療效果。皮下藥物輸送系統由注射器、分配系統和插入皮下的藥物容器組成。

根據美國多發性硬化症協會的數據，2017 年美國估計有 100 萬成年人患有多發性硬化症。

慢性病增加

糖尿病、自體自體免疫疾病和心血管疾病等慢性病的盛行率不斷上升，推動了對皮下給藥裝置的需求。這些設備為這些疾病的長期給藥提供了有效的給藥方式。因此，慢性病的快速增加預計將推動市場成長。

缺乏健康意識

在新興和不已開發國家，人們對藥物、各種疾病和藥物傳輸技術知之甚少。由於衛生保健設施不足，與慢性病相關的死亡人數不斷增加。大多數農村人口仍未被發現和治療。此外，由於藥物和給藥設備的成本高昂，皮下給藥裝置的使用在許多國家受到限制。這是阻礙市場擴張的重要因素。

對生物相似藥和生技藥品的需求不斷成長

由於生物製藥和生物相似藥的快速普及，全球皮下給藥裝置市場的市場參與企業正享受著眾多的成長機會。全球對皮下給藥系統的需求是由對治療慢性病的各種藥物的不斷成長的需求所推動的。生物製藥和生物相似藥的使用不斷增加，通常需要皮下給藥，這增加了對這些藥物的專用輸送設備的需求。

使用不當導致針刺傷

針刺傷和藥物輸送給藥只是在沒有正確資訊和說明的情況下不正確使用皮下給藥裝置時可能出現的兩個問題。這使得患者更難以在多種藥物傳輸選項之間進行選擇。此外，與針頭相關的血液感染疾病的風險可能最終成為一個主要障礙。

COVID-19 的影響：

皮下給藥裝置市場與整個醫療保健產業一樣，受到了 COVID-19 爆發的重大影響。由於人們越來越關注家庭治療、遠距醫療保健和減少醫院就診，因此對自我給藥設備的需求越來越大。此次疫情凸顯了高效給藥技術的重要性，並刺激了皮下給藥市場的創新和投資。

預計在預測期內，穿戴式注射器細分市場將成為最大的細分市場

預計穿戴式注射器細分市場在預測期內將是最大的。這與針刺傷的增加以及注射使用引起的血源性疾病的風險增加有關。透過穿戴式注射器可以有效率地給藥高黏度、大容量的生物製藥。稱為穿戴式注射器的數位藥物給藥工具非常方便，可以幫助患者在正確的時間給藥正確的劑量。

神經系統疾病領域預計在預測期內複合年成長率最高。

神經系統疾病領域預計在預測期內複合年成長率最高。這些裝置能夠長期控制並穩定地釋放藥物。在癲癇和帕金森氏症等持續藥物水平很重要的神經系統疾病中，這種控制釋放可以幫助有效控制症狀。這些設備的設計通常考慮到患者的舒適度，並且可以最大限度地減少治療的侵入性。

比最大的地區

預計北美在預測期內將佔據最大的市場佔有率。這是由於各種慢性病的盛行率不斷上升以及人們對藥物和給藥裝置的需求不斷增加。該市場的特點有很多因素，包括發達的醫療保健基礎設施、該地區多個主要製造商、每個製造商不同的發展策略以及不斷增加的醫療保健支出等，是其成長的重要原因。

複合年成長率最高的地區：

預計亞太地區在預測期內複合年成長率最高。這主要是由於該地區人民不健康的飲食習慣導致糖尿病人口迅速增加。可支配收入的增加、糖尿病管理意識的提高以及醫療保健支出的增加是近期推動市場成長的主要因素。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球皮下給藥裝置市場：依產品

  • 預充式注射器
  • 自動注射器
  • 穿戴式注射器
  • 筆式注射器
  • 無針注射器
  • 其他產品

第6章全球皮下給藥裝置市場：依類型

  • 一次性的
  • 可重複使用的

第7章全球皮下給藥裝置市場：依適應症分類

  • 神經系統疾病
  • 腫瘤疾病
  • 自體免疫疾病
  • 眼科疾病
  • 過敏及感染疾病
  • 荷爾蒙失調
  • 其他適應症

第8章全球皮下給藥裝置市場：依配銷通路

  • 醫院
  • 零售藥房
  • 線上藥房
  • 其他配銷通路

第9章全球皮下給藥裝置市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Medtronic Plc
  • Gerresheimer AG
  • Elcam Medical Group
  • Insulet Corporation
  • Ypsomed AG
  • Becton, Dickinson and Company
  • PharmaJet
  • Unilife Corporation
  • In life Sciences
  • West Pharmaceutical Services, Inc.
  • Novo Nordisk
  • Eli Lilly
  • Merck
  • AstraZeneca
  • Amgen
  • Enable Injections
  • Consort Medical Plc
  • Wilhelm Haselmeier GmbH & Co. KG
Product Code: SMRC24650

According to Stratistics MRC, the Global Subcutaneous Drug Delivery Devices Market is accounted for $30.9 billion in 2023 and is expected to reach $65.4 billion by 2030 growing at a CAGR of 11.3% during the forecast period. Medical equipment called subcutaneous drug delivery devices is used to give patients medication subcutaneously, or under the skin. This method of drug delivery is preferred over others because it enables the drug's constant and continuous release into circulation, leading to less side effects and more consistent therapeutic advantages. Subcutaneous drug delivery systems consist of a syringe inserted under the skin, a distribution system, and a pharmaceutical container.

According to the National Multiple Sclerosis Society, an estimated 1.0 million adults were reported to be living with multiple sclerosis in the U.S. in 2017.

Market Dynamics:

Driver:

Rise in Chronic Diseases

Increasing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions has driven the demand for subcutaneous drug delivery devices. These devices offer an effective way to administer medication for long-term management of these ailments. Therefore, the rapidly growing prevalence of chronic diseases is expected to drive the growth of the market.

Restraint:

Lack of health awareness

In emerging and undeveloped economies, there's a dearth of knowledge about pharmaceuticals, various ailments, and drug delivery technologies. Chronic illness-related fatalities rise as a result of inadequate healthcare facilities. Most rural residents continue to go undetected and untreated. Furthermore, the use of subcutaneous drug delivery devices is limited in a number of countries by the high cost of medications and drug administration equipment. This is a significant element that might impede market expansion.

Opportunity:

Growing demand for biosimilar and biologics

The market participants in the worldwide subcutaneous drug delivery devices market have a number of growth opportunities thanks to the quick rise in popularity of biologic and biosimilar medications. Global demand for subcutaneous drug delivery systems is being driven by the increasing need for different medications to treat chronic conditions. The growing use of biologics and biosimilars, which often require subcutaneous administration, has bolstered the demand for specialized delivery devices tailored for these medications.

Threat:

Improper use may give rise to needle stick injuries

Needlestick injuries and drug overdoses are only two of the issues that can arise from using subcutaneous medication delivery devices improperly without the right information and instruction. This can make it more difficult for the patients to choose between several drug delivery options. Furthermore, the dangers of blood-borne infections linked to injection needles might end up being a significant obstacle.

COVID-19 Impact:

The market for subcutaneous medication delivery devices has been significantly impacted by the COVID-19 epidemic, as has the whole healthcare sector. Self-administration devices are becoming more and more in demand as a result of the growing emphasis on home-based treatment, remote healthcare, and reducing hospital visits. The epidemic has brought attention to the significance of efficient medication delivery techniques, spurring innovation and investment in the subcutaneous drug delivery market.

The wearable injectors segment is expected to be the largest during the forecast period

The wearable injectors segment is expected to be the largest during the forecast period. This is linked to the increase in needle stick injuries as well as the increased risk of blood-borne illnesses from injection usage. The high-viscosity, high-volume biologic medications are administered with exceptional efficiency by the wearable injectors. Digital medicine administration tools called wearable injectors are convenient and assist patients in giving precise dosages at the appropriate times.

The neurological disorders segment is expected to have the highest CAGR during the forecast period

The neurological disorders segment is expected to have the highest CAGR during the forecast period. These devices can provide a controlled and steady release of medications over an extended period. For neurological disorders where consistent medication levels are crucial, such as in epilepsy or Parkinson's disease, this controlled release can help manage symptoms effectively. These devices are often designed for patient comfort, minimizing the invasiveness of treatments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the increased prevalence of various chronic diseases resulted in the huge demand for drugs and drug delivery devices amongst the population. The market is growing due to a number of significant reasons, including the presence of improved healthcare infrastructure, the presence of multiple major manufacturers in the region and the different developmental strategies they have followed, and rising healthcare spending.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. This is majorly attributed to the rapidly growing diabetic population in the region owing to the unhealthy food habits of the people. The rising disposable income, growing awareness regarding the diabetes management, and rising healthcare expenditure are the major factors that will drive the growth of the market in the forthcoming future.

Key players in the market:

Some of the key players in Subcutaneous Drug Delivery Devices market include Medtronic Plc, Gerresheimer AG, Elcam Medical Group, Insulet Corporation, Ypsomed AG, Becton, Dickinson and Company, PharmaJet, Unilife Corporation, In life Sciences , West Pharmaceutical Services, Inc., Novo Nordisk, Eli Lilly, Merck, AstraZeneca, Amgen, Enable Injections, Consort Medical Plc and Wilhelm Haselmeier GmbH & Co. KG.

Key Developments:

In November 2023, The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

In October 2023, Eli Lilly gives $20M upfront cash injection to Elektrofi in next-gen subcutaneous drug collab. Eli Lilly has tapped up drug delivery specialist Elektrofi to see whether the biotech's microparticle formulation technology could produce the next generation of subcutaneously administered therapies.

Products Covered:

  • Prefilled Syringes
  • Auto-Injectors
  • Wearable Injectors
  • Pen Injectors
  • Needle-Free Injectors
  • Other Products

Types Covered:

  • Disposable
  • Reusable

Indications Covered:

  • Neurological Disorders
  • Oncology Disorders
  • Auto-immune Disorders
  • Ophthalmic Disorders
  • Allergy & Infectious Disorders
  • Hormonal Disorders
  • Other Indications

Distribution Channels Covered:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Subcutaneous Drug Delivery Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Prefilled Syringes
  • 5.3 Auto-Injectors
  • 5.4 Wearable Injectors
  • 5.5 Pen Injectors
  • 5.6 Needle-Free Injectors
  • 5.7 Other Products

6 Global Subcutaneous Drug Delivery Devices Market, By Type

  • 6.1 Introduction
  • 6.2 Disposable
  • 6.3 Reusable

7 Global Subcutaneous Drug Delivery Devices Market, By Indication

  • 7.1 Introduction
  • 7.2 Neurological Disorders
  • 7.3 Oncology Disorders
  • 7.4 Auto-immune Disorders
  • 7.5 Ophthalmic Disorders
  • 7.6 Allergy & Infectious Disorders
  • 7.7 Hormonal Disorders
  • 7.8 Other Indications

8 Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Retail Pharmacies
  • 8.4 Online Pharmacies
  • 8.5 Other Distribution Channels

9 Global Subcutaneous Drug Delivery Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic Plc
  • 11.2 Gerresheimer AG
  • 11.3 Elcam Medical Group
  • 11.4 Insulet Corporation
  • 11.5 Ypsomed AG
  • 11.6 Becton, Dickinson and Company
  • 11.7 PharmaJet
  • 11.8 Unilife Corporation
  • 11.9 In life Sciences
  • 11.10 West Pharmaceutical Services, Inc.
  • 11.11 Novo Nordisk
  • 11.12 Eli Lilly
  • 11.13 Merck
  • 11.14 AstraZeneca
  • 11.15 Amgen
  • 11.16 Enable Injections
  • 11.17 Consort Medical Plc
  • 11.18 Wilhelm Haselmeier GmbH & Co. KG

List of Tables

  • Table 1 Global Subcutaneous Drug Delivery Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 4 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 5 Global Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 6 Global Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 7 Global Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 8 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 10 Global Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 11 Global Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 12 Global Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 13 Global Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 14 Global Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 15 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 16 Global Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 17 Global Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 18 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 19 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 20 Global Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 21 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 22 Global Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 23 Global Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 24 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 25 North America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 28 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 29 North America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 30 North America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 31 North America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 32 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 33 North America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 34 North America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 35 North America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 36 North America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 37 North America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 38 North America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 39 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 40 North America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 41 North America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 42 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 43 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 44 North America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 45 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 46 North America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 47 North America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 48 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 49 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 52 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 53 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 54 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 55 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 56 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 57 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 58 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 59 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 60 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 61 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 62 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 63 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 64 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 65 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 66 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 67 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 68 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 69 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 70 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 71 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 72 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 73 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 76 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 77 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 78 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 79 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 80 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 82 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 83 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 84 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 85 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 86 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 87 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 88 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 89 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 90 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 91 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 92 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 93 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 94 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 95 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 96 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 97 South America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 100 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 101 South America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 102 South America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 103 South America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 104 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 105 South America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 106 South America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 107 South America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 108 South America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 109 South America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 110 South America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 111 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 112 South America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 113 South America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 114 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 115 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 116 South America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 117 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 118 South America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 119 South America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 120 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 121 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 124 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 125 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 126 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 127 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 128 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 129 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 130 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 131 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 132 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 133 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 134 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 135 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 136 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 137 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 138 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 139 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 140 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 141 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 142 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 143 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 144 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)